Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TWIST BIOSCIENCE CORPORATION

(TWST)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2021 11/22/2021 11/23/2021 11/24/2021 11/26/2021 Date
110.62(c) 98.17(c) 96.69(c) 95.8(c) 94.99(c) Last
718 094 2 204 502 1 393 417 706 281 280 967 Volume
-1.36% -11.25% -1.51% -0.92% -0.85% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 188 M - -
Net income 2022 -246 M - -
Net cash position 2022 131 M - -
P/E ratio 2022 -20,0x
Yield 2022 -
Sales 2023 245 M - -
Net income 2023 -240 M - -
Net cash position 2023 125 M - -
P/E ratio 2023 -20,4x
Yield 2023 -
Capitalization 4 715 M 4 715 M -
EV / Sales 2022 24,4x
EV / Sales 2023 18,7x
Nbr of Employees 652
Free-Float 92,6%
More Financials
Company
Twist Bioscience Corporation is a synthetic biology and genomics company. The Company has developed a Twist Bioscience DNA synthesis platform to industrialize the engineering of biology. The core of its platform is a technology that provides a new method of manufacturing synthetic DNA by writing DNA on a silicon chip. The Company has developed multiple products derived from synthetic DNA and its versatile DNA... 
Sector
Pharmaceuticals
Calendar
02/10Earnings Release
More about the company
Ratings of Twist Bioscience Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about TWIST BIOSCIENCE CORPORATION
11/24Twist Bioscience to Present at Upcoming Virtual Conferences
BU
11/23INSIDER SELL : Twist Bioscience
MT
11/23TWIST BIOSCIENCE CORP Change in Directors or Principal Officers (form 8-K/A)
AQ
11/23Twist Bioscience Corporation Announces Executive Changes
CI
11/23Health Care Stocks Nudging Back Onto Positive Ground
MT
11/23Health Care Stocks Partially Recover From Morning Slide
MT
11/23Barclays Adjusts Twist Bioscience PT to $130 From $140, Maintains Overweight Rating
MT
11/23Evercore ISI Adjusts Twist Bioscience PT to $98 From $110, Maintains In Line Rating
MT
11/23Baird Adjusts Price Target on Twist Bioscience to $113 From $130, Reiterates Outperform..
MT
11/23TWIST BIOSCIENCE CORP Management's discussion and analysis of financial condition and ..
AQ
11/22TWIST BIOSCIENCE : Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results - Fo..
PU
11/22TWIST BIOSCIENCE : Enters into Definitive Agreement to Acquire Abveris, Bolstering Biophar..
PU
11/22TWIST BIOSCIENCE CORP : Unregistered Sale of Equity Securities, Financial Statements and E..
AQ
11/22Twist Bioscience Reports Widened Fiscal Fourth-Quarter Loss as Revenue Rises; Plans to ..
MT
11/22Health Care Stocks Mixed Pre-Bell Monday
MT
More news
News in other languages on TWIST BIOSCIENCE CORPORATION
11/23VENTE D'INITIÉS : Twist Bioscience
11/23Les actions du secteur de la santé retrouvent un terrain positif
11/23Les actions du secteur de la santé se remettent partiellement de leur chute du matin
11/22Twist Bioscience annonce une perte élargie au quatrième trimestre fiscal alors que les ..
11/22Les actions du secteur de la santé sont mitigées avant le lundi de la cloche
More news
Analyst Recommendations on TWIST BIOSCIENCE CORPORATION
More recommendations
Chart TWIST BIOSCIENCE CORPORATION
Duration : Period :
Twist Bioscience Corporation Technical Analysis Chart | TWST | US90184D1000 | MarketScreener
Technical analysis trends TWIST BIOSCIENCE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 94,99 $
Average target price 111,83 $
Spread / Average Target 17,7%
EPS Revisions
Managers and Directors
Emily Marine Leproust Chairman, President & Chief Executive Officer
James M. Thorburn Chief Financial Officer
Aaron K. Sato Chief Scientific Officer
Siyuan Chen Chief Technology Officer
Patrick Weiss Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
TWIST BIOSCIENCE CORPORATION-32.77%4 715
CSL LIMITED10.18%101 196
WUXI BIOLOGICS (CAYMAN) INC.0.58%56 285
SAMSUNG BIOLOGICS CO.,LTD.5.33%48 100
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-0.80%35 680